Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2MFD0
|
|||
| Drug Name |
GS-1427
|
|||
| Indication | Inflammation [ICD-11: 1A00-CA43.1] | Phase 1 | [1] | |
| Inflammatory bowel disease [ICD-11: DD72; ICD-10: K50-K52] | Phase 1 | [1] | ||
| Company |
Gilead
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Integrin alpha-4/beta-7 (ITGA4/B7) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Gilead | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.